4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-016085
Chief Executive Officer gave up 794 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2020-03-02 | Shares withheld for taxes | −794 | $52.74 | $41,876 | 171,526 | D |
Loading xslF345X03/doc4.xml…